Kanabo Group (STU:3WD) Debt-to-Equity: 0.04 (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kanabo Group Debt-to-Equity?

Kanabo Group STU:3WD Debt-to-Equity is 0.04 as of Jun. 2024.

Kanabo Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.16 Mil. Kanabo Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.09 Mil. Kanabo Group's Total Stockholders Equity for the quarter that ended in Jun. 2024 was €7.00 Mil. Kanabo Group's debt to equity for the quarter that ended in Jun. 2024 was 0.03.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Kanabo Group's Debt-to-Equity or its related term are showing as below:

STU:3WD's Debt-to-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.41
* Ranked among companies with meaningful Debt-to-Equity only.

Kanabo Group  (STU:3WD) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Kanabo Group Debt-to-Equity Related Terms

Kanabo Group Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Kanabo Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kanabo Group Debt-to-Equity Chart

Kanabo Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial 0.00 -10.88 0.00 0.06 0.04

Kanabo Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.06 0.04 0.04 0.04

STU:3WD vs HCA, THC, EHC: Debt-to-Equity Comparison

For the Medical Care Facilities subindustry, Kanabo Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kanabo Group Debt-to-Equity vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kanabo Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Kanabo Group's Debt-to-Equity falls into.


Kanabo Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Kanabo Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.154 + 0.161) / 8.721
=0.04

Kanabo Group's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.157 + 0.086) / 7.002
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of 0.04 mean?
Kanabo Group (STU:3WD) has a Debt-to-Equity of 0.04 as of Jun. 2024. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Kanabo Group and its competitors.
Is Kanabo Group's Debt-to-Equity too high?
Kanabo Group's current Debt-to-Equity is 0.04. The Healthcare Providers & Services industry median Debt-to-Equity is 0.41. Kanabo Group's value of 0.04 is 90.2% below this industry median.
How does Kanabo Group's Debt-to-Equity compare to HCA and THC?
Kanabo Group's Debt-to-Equity of 0.04 can be compared against companies in the Healthcare Providers & Services industry. The industry median Debt-to-Equity is 0.41. Kanabo Group's value of 0.04 is 90.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.41, based on 557 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kanabo Group's current Debt-to-Equity of 0.04 is 90.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Kanabo Group and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kanabo Group's current Debt-to-Equity is 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kanabo Group stock overvalued right now?
Kanabo Group (STU:3WD) has a current Debt-to-Equity of 0.04. The current Debt-to-Equity is 0.04 and 90.2% below the Healthcare Providers & Services industry median of 0.41. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Kanabo Group (STU:3WD), the current Debt-to-Equity is 0.04 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kanabo Group Business Description

Address 137-139 Brent Street, Churchill House, London, GBR, NW4 4DJ
Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment, which derives key revenue, includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom and Israel.